#SingleDomainAntibody
LightNews LightNews
nanotag.bsky.social
#CellBio2025 in Philadelphia has come to a close!
Thanks to everyone who stopped by the #NanoTag booth 🦙 – great conversations and insights all around.
We were excited to hear how our sdAb tools are driving your new discoveries 📄👏

#SingleDomainAntibody
#ALFAsystem
#SmartSecondaries
December 11, 2025 at 2:07 PM
nanotag.bsky.social
NanoTag will be at #Neurizons2026!
Visit our booth to explore #nanobody-based tools for super-resolution microscopy and protein analysis 🦙🧠🔬.

👋See you at Max Planck Institute for Multidisciplinary Sciences @mpi-nat.bsky.social

#Neuroscience #SingleDomainAntibody
May 15, 2026 at 10:02 AM
antibodytx.bsky.social
Antibody Therapeutics(IF=4.5, Oxford University Press) 🎇📷 Novel Modality | Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design academic.oup.com/abt/article/... #SingleDomainAntibody #LightChainOnly #BispecificAntibody
January 27, 2026 at 1:11 AM
nanotag.bsky.social
Greetings from #Horizons2026 in our hometown Göttingen! 🦙🔬Our team is here showcasing our #nanobody -based technologies and services.

Come by our booth to explore how #NanoTag might support your research!

#SingleDomainAntibody #FluoTag #SmartSecondaries #ALFAsystem
@horizonsmolbio.bsky.social
September 7, 2026 at 2:23 PM
antibodytx.bsky.social
Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Review Highlight -Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate
academic.oup.com/abt/article/...
#solidtumors #tumorpenetration #singledomainantibody #antibodydrugconjugate
Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate
Statement of Significance: The research on ADCs is advancing toward an innovative transitional phase. Small antibody fragments or other structurally derive
academic.oup.com
June 7, 2026 at 4:05 PM
stonedhshi.bsky.social
A new paper just reached "corrected proof" stage on our journal @antibodytx.bsky.social titled "Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design".

doi.org/10.1093/abt/...

#Antibody #SingleDomainAntibody #Bispecific #OpenAccess
Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design
AbstractBackground. As one of the most promising classes of next-generation antibody therapeutics, bispecific antibodies (bsAbs) have gained increasing att
doi.org
October 24, 2025 at 4:43 AM